Clinical Trials Logo

Filter by:
NCT ID: NCT05582525 Completed - Clinical trials for Lower Urinary Tract Symptoms

COVID-19 Vaccines and the Development of New LUTS

Start date: February 1, 2022
Phase:
Study type: Observational

This study was conducted to check whether coronavirus disease 2019 (COVID) vaccines have a relationship with LUTS or not in a healthy and mostly medically free population.

NCT ID: NCT05581264 Completed - Diabetes Mellitus Clinical Trials

Diabetes Self-Management Educational Program

DSMEP
Start date: September 28, 2021
Phase: N/A
Study type: Interventional

Diabetes mellitus is the third most prevalent chronic disease globally. It is a metabolic disorder characterized by elevated blood glucose because of impaired insulin production, reduced insulin effectiveness, or both. It is a major contributor to physical disability and impaired quality of life. Diabetes Self-Management programs help to control blood glucose, reduce hospitalization, and increase compliance; however, the program is underutilized in primary care settings globally, due to cognitive, financial, behavioral, and emotional factors. Addressing the increasing trend in diabetes, Jordan is currently in need of a diabetes self-management program that promotes patient empowerment and overall well-being. The primary aim of this study was to investigate the effectiveness of a diabetes self-management education program for patients with type 2 diabetes in improving self-care, medication adherence, illness perception, health-related quality of life, and glycemic control (HbA1c level). This study is a two-arm randomized controlled trial study of patients with type 2 diabetes attending two outpatients' diabetes clinic settings in Jordan. The education program and also usual medical care were applied to the intervention group, only usual medical care was applied to the control group.

NCT ID: NCT05563818 Completed - Schizophrenia Clinical Trials

Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia

Start date: November 9, 2021
Phase:
Study type: Observational

Brief Summary: Definition: A short description of the clinical study, including a brief statement of the clinical study's hypothesis, written in language intended for the lay public. Limit: 5000 characters. The purpose of this study is to investigate the relationship between speech features and severity of positive and negative clinical symptoms in Arabic speaking patients with schizophrenia. Individuals will be invited to participate in this study because (1) they have a confirmed clinical diagnosis of schizophrenia; (2) they plan to receive routine clinical care for schizophrenia at one of the four participating sites; (3) they speak Arabic as a first language. Participants must be between the ages of 18-65 years. Participation will involve seven visits consisting of one baseline visit and six monthly follow-up visits. All participants will continue to receive routine clinical care. Participation in this research will involve providing speech samples using standardized tasks collected using an electronic device. Additionally, study team members will assess positive and negative symptoms of schizophrenia using validated questionnaires.

NCT ID: NCT05542394 Completed - Clinical trials for Plasma Levels of Different Curcuminoids Preparations

Determination of Pharmacokinetics of Different Curcuminoids Preparations: Pilot Study

Start date: September 20, 2022
Phase: N/A
Study type: Interventional

This pilot study aims to investigate the pharmacokinetics of a novel curcuminoid preparation with suggested high bioavailability due to its solubility in water, compared to two standard hydrophobic formulations. The findings of this study will help the health care providers and community to select suitable formulation.

NCT ID: NCT05539742 Completed - Lipemia Clinical Trials

Comparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The main objective is to investigate if foods high in coconut oil (MCFA) or palm oil (LCFA) have different impacts on postprandial blood lipid levels and appetite via a visual analog scale (VAS).

NCT ID: NCT05530564 Completed - Pain Clinical Trials

Effect of Low-pressure Pneumoperitoneum on Pain and Inflammation in Laparoscopic Cholecystectomy

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of low-pressure pneumoperitoneum on post operative pain and inflammation in patients undergoing elective laparoscopic cholecystectomy by comparing it to standard practice.

NCT ID: NCT05496283 Completed - Complete Edentulism Clinical Trials

Effect of Denture Adhesives on Complete Denture Patients

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

The effect of using denture adhesives on patient satisfaction with complete dentures; A randomized clinical trial. The study evaluates the effect of using 3 types of denture adhesives on patient satisfaction and quality of life of complete denture patients

NCT ID: NCT05483348 Completed - Uterine Bleeding Clinical Trials

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection

Start date: February 17, 2022
Phase:
Study type: Observational

To determine the predictive factors of endometrial ablation failure in the management of uterine bleeding.

NCT ID: NCT05470764 Completed - Healthy Subjects Clinical Trials

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Start date: May 30, 2021
Phase: Phase 1
Study type: Interventional

The present study is a comparative bioavailability study performed to assess bioequivalence between a Test medication (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets manufactured by PrJSC "Pharmaceutical firm "Darnitsa" [Ukraine]) and a Reference medication (marketed medicinal product TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets [manufactured by Servier (Ireland) Industries Ltd]) in healthy adult volunteers under fasting conditions.

NCT ID: NCT05466084 Completed - Hernia Clinical Trials

Tissue Glue vs Metallic Tackers in Mesh Fixation During TAPP Repair.

TAVGLU
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This is a randomized control trial intending to study the clinical difference between different mesh fixation techniques in laparoscopic TAPP hernioplasty of inguinal hernia for adults with unilateral and bilateral inguinal hernia , two techniques are tissue glue and surgical tackers , the target population will be divided according to an electronic generated randomization into two groups , they will be compared according to multiple variables which includes but not limited to : procedure time, early post op complication , post-operative pain , late complications , short term and long term recurrence rates .